Activ Surgical, a US-based robotic surgery technology provider backed by electronics manufacturer Sony, secured $15m yesterday in a funding round led by venture capital firm Artis Ventures.
DNS Capital, GreatPoint Ventures (GPV), LRVHealth, Rising Tide VC and Tao Capital Partners filled out the round.
Founded in 2017, Activ is developing software that will use artificial intelligence technology to power autonomous surgery systems. It will use the cash to commercialise its products in the United States and increase its presence in Europe.
Sony had backed the company’s $11m series A round in October 2019 through its Sony Innovation Fund, participating alongside lead investor DNS Capital as well as GPV, Mintz, Rising Tide Financial, Tao Capital Partners and WS Investment Company.
Activ had raised $12.9m from unnamed investors in July 2019 according to a securities filing, following $1.5m in a 2017 equity round and $2m in debt financing in April 2018 according to separate filings.
